Google has announced a new feature in its Google Lens image detection app that enables users to identify and diagnose skin conditions at the first stage.
 |
| Learn about the Google Lens tool and its relationship to medicine |
The Google Lens camera can be used to photograph any obscure or unknown element on the skin. The tool will analyze the image and search for similar images on the Internet, then present it to the user to determine the most appropriate image and the closest to the actual situation, in addition to providing him with information obtained from Articles published on the Internet about this case.
In addition, the Google Lens application can detect other areas of the human body, which enables it to describe the problems that the user suffers from and obtain an initial estimate of his condition, before going to the doctor.
Google knows that many people use the traditional search engine to search for symptoms and diseases using typed search terms, but this feature will help speed up the search process and produce more meaningful results.
It is expected that the new feature, the launch date of which has not been disclosed by Google, will be available gradually over the coming weeks.
Google previously stated that the main objective of the new display feature for search results is to provide information and data to users about the condition to be searched for, and not to diagnose the condition in a definitive and final way, in addition to that it is not considered a substitute for specialized medical advice.
Google Lens is designed as a tool used for visual analysis of images to provide search results. Google Lens is similar to Google's regular search engine, and what distinguishes it is the ability to provide the information the user needs, by photographing his smartphone or any image, without the need to type search terms.
Two years ago, Google announced a health app called "DermAssist" that diagnoses skin diseases using artificial intelligence techniques. This application has been approved by the European Union, but it has not been authorized by the US Food and Drug Administration (FDA) yet, and the application is currently in the process of testing and development.